麻豆AV

麻豆AV鈥檚聽聽(CRBS) recently saw its six-year $4.2M funding for structural biology and biophysics from the Fonds de recherche du Qu茅bec 鈥� secteur sant茅 (FRQS) renewed following a near-perfect evaluation of 98/100 鈥� 鈥渆xceptional鈥� under the FRQS scoring system. Added to this, the CRBS also received matching support from various 麻豆AV and clinical and research partners totalling 5.8M, including in kind funds, bringing expected funds to a round $10M.聽聽

鈥淐ontinued and expanded funding of CRBS from the FRQS is transformative for the biophysics and structural biology research community at 麻豆AV,鈥� says CRBS director and Professor of Biochemistry Martin Schmeing, PhD. 鈥淐RBS now boasts 50 麻豆AV research lab across four faculties, and FRQS funding allows us to deliver an 鈥榚xtremely ambitious鈥� (per FRQS reviewers) slate of offerings, support and activities.鈥澛�

Martin Schmeing

The CRBS is dedicated to facilitating cutting-edge research in the area of biophysical and structural biology, to better understand disease mechanisms and develop better therapeutics in areas such as infectious disease and neurology.聽聽

A few key areas the CRBS will develop with their renewed funding:聽聽

• Microgrants: for new collaborations and infrastructure;聽
• Training: studentship, travel awards, workshops, bootcamps, Tremplin career development program;聽
• Dissemination: CRBS symposium, bench to bedside sessions, Science POP competition;
• Outreach: with high school and CEGEP students, Indigenous organizations and the general public;
• Technical support: in biophysics and structural biology to Centre members and the broader research community.聽